Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Quinidine Versus Verapamil in Short-coupled Idiopathic Ventricular Fibrillation
NCT05593757Phase 2Unknown
- Sponsor
- University of Amsterdam
- Start
- Oct 2022
- Primary completion
- Sep 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of quinidine and verapamil in idiopathic ventricular fibrillation (IVF) (2 arms), sponsored by University of Amsterdam. Primary endpoint: Sustained ventricular arrhythmia at 3 years. Status: unknown.
02
Drugs
quinidineverapamil
03
Conditions
idiopathic ventricular fibrillation (IVF)
Beyond the preview
Go deeper on NCT05593757.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05593757.